Search research articles
Contact Us
Filters
Showing results (171-180 of 208) with videos related to
Page
of 21
Sort By:
Molecular Cancer Research : MCR
|
March 29, 2019
Whole-Genome and Transcriptional Analysis of Treatment-Emergent Small-Cell Neuroendocrine Prostate Cancer Demonstrates Intraclass Heterogeneity
Rahul R Aggarwal, David A Quigley, Jiaoti Huang, et al.
Nature Communications
|
August 5, 2024
Proteostasis perturbation of N-Myc leveraging HSP70 mediated protein turnover improves treatment of neuroendocrine prostate cancer
Pengfei Xu, Joy C Yang, Bo Chen, et al.
European Urology
|
August 2, 2016
Enzalutamide in Men with Chemotherapy-naïve Metastatic Castration-resistant Prostate Cancer: Extended Analysis of the Phase 3 PREVAIL Study
Tomasz M Beer, Andrew J Armstrong, Dana Rathkopf, et al.
Circulation
|
August 30, 2021
Cardiovascular Safety of Degarelix Versus Leuprolide in Patients With Prostate Cancer: The Primary Results of the PRONOUNCE Randomized Trial
Renato D Lopes, Celestia S Higano, Susan F Slovin, et al.
JAMA Oncology
|
September 23, 2021
Prognosis Associated With Luminal and Basal Subtypes of Metastatic Prostate Cancer
Rahul Aggarwal, Nicholas R Rydzewski, Li Zhang, et al.
JAMA
|
May 26, 2018
Effect of Intravesical Instillation of Gemcitabine vs Saline Immediately Following Resection of Suspected Low-Grade Non-Muscle-Invasive Bladder Cancer on Tumor Recurrence: SWOG S0337 Randomized Clinical Trial
Edward M Messing, Catherine M Tangen, Seth P Lerner, et al.
Journal of Surgical Oncology
|
August 27, 2016
Renal cell carcinoma with inferior vena cava involvement: Prognostic effect of tumor thrombus consistency on cancer specific survival
Rene Mager, Siamak Daneshmand, Christopher P Evans, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
July 25, 2020
Cancer and Leukemia Group B 90203 (Alliance): Radical Prostatectomy With or Without Neoadjuvant Chemohormonal Therapy in Localized, High-Risk Prostate Cancer
James A Eastham, Glenn Heller, Susan Halabi, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
July 31, 2020
Copy Number Loss of 17q22 Is Associated with Enzalutamide Resistance and Poor Prognosis in Metastatic Castration-Resistant Prostate Cancer
Xiangnan Guan, Duanchen Sun, Eric Lu, et al.
The New England Journal of Medicine
|
June 1, 2026
Perioperative Apalutamide in High-Risk Localized Prostate Cancer
Mary-Ellen Taplin, Martin Gleave, Neal D Shore, et al.
Page
of 21
Search research articles
Search
Showing results (171-180 of 208) with videos related to
Sort By:
Page
of 21
Molecular Cancer Research : MCR
|
March 29, 2019
Whole-Genome and Transcriptional Analysis of Treatment-Emergent Small-Cell Neuroendocrine Prostate Cancer Demonstrates Intraclass Heterogeneity
Rahul R Aggarwal, David A Quigley, Jiaoti Huang, et al.
Nature Communications
|
August 5, 2024
Proteostasis perturbation of N-Myc leveraging HSP70 mediated protein turnover improves treatment of neuroendocrine prostate cancer
Pengfei Xu, Joy C Yang, Bo Chen, et al.
European Urology
|
August 2, 2016
Enzalutamide in Men with Chemotherapy-naïve Metastatic Castration-resistant Prostate Cancer: Extended Analysis of the Phase 3 PREVAIL Study
Tomasz M Beer, Andrew J Armstrong, Dana Rathkopf, et al.
Circulation
|
August 30, 2021
Cardiovascular Safety of Degarelix Versus Leuprolide in Patients With Prostate Cancer: The Primary Results of the PRONOUNCE Randomized Trial
Renato D Lopes, Celestia S Higano, Susan F Slovin, et al.
JAMA Oncology
|
September 23, 2021
Prognosis Associated With Luminal and Basal Subtypes of Metastatic Prostate Cancer
Rahul Aggarwal, Nicholas R Rydzewski, Li Zhang, et al.
JAMA
|
May 26, 2018
Effect of Intravesical Instillation of Gemcitabine vs Saline Immediately Following Resection of Suspected Low-Grade Non-Muscle-Invasive Bladder Cancer on Tumor Recurrence: SWOG S0337 Randomized Clinical Trial
Edward M Messing, Catherine M Tangen, Seth P Lerner, et al.
Journal of Surgical Oncology
|
August 27, 2016
Renal cell carcinoma with inferior vena cava involvement: Prognostic effect of tumor thrombus consistency on cancer specific survival
Rene Mager, Siamak Daneshmand, Christopher P Evans, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
July 25, 2020
Cancer and Leukemia Group B 90203 (Alliance): Radical Prostatectomy With or Without Neoadjuvant Chemohormonal Therapy in Localized, High-Risk Prostate Cancer
James A Eastham, Glenn Heller, Susan Halabi, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
July 31, 2020
Copy Number Loss of 17q22 Is Associated with Enzalutamide Resistance and Poor Prognosis in Metastatic Castration-Resistant Prostate Cancer
Xiangnan Guan, Duanchen Sun, Eric Lu, et al.
The New England Journal of Medicine
|
June 1, 2026
Perioperative Apalutamide in High-Risk Localized Prostate Cancer
Mary-Ellen Taplin, Martin Gleave, Neal D Shore, et al.
Page
of 21